drug
Creon
Marketedupdated 5mo agoby $ABBV AbbVie Inc.
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying Creon
- phase2Phase 2 Study to Assess the Safety and Efficacy of ANG003
- N/AClinical Evaluation of Two Cosmetic Contact Lenses
- phase4Pancreatic Enzyme Replacement Therapy for Acute Pancreatitis-Associated Exocrine Pancreatic Insufficiency
- phase2Pancreaze (Pancrelipase) for Patients With Pancreatic Adenocarcinoma With Cachexia and Exocrine Pancreatic Insufficiency
- N/AEffect of Enzyme Therapy on Protein Metabolism in Chronic Pancreatitis
- phase4Study to Evaluate Symptoms of Exocrine Pancreatic Insufficiency in Adult Participants With Cystic Fibrosis or Chronic Pancreatitis Treated With Creon
- —Effect of CREON on Exocrine Pancreatic Insufficiency (EPI) Symptoms
- phase4A Study to Compare US Marketed Creon Manufactured With a Modernized Process at an Alternate Manufacturing Site and Manufactured With the Approved Manufacturing Process at an Alternate Active Pharmaceutical Ingredient Site, in Participants With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
News(1)
- Is the biotech capital of the world moving?Replimune finally wins FDA approval, the role of tau in Alzheimer's, and more biotech news from The Readoutstat · 2mo ago
Data sources
last refreshed 2h ago
Found something off?
comments(0)
5-min edit window · permanent after that